2m 2m 2m 2m 2m 2m 2m
Innoviva (INVA)
NASDAQ
$21.35+$0.29 (+1.38%)
Price as of Oct 23, 2026 4:09 AM EDT- $1.5BMarket Cap
- 15.33%1-Year Change
- BiotechnologyIndustry
Innoviva (INVA)
$21.35+$0.29 (+1.38%)
INVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.06 | ||
Change | +$0.15 (+0.72%) | ||
Open | $21.05 | ||
High | $21.27 | ||
Low | $20.92 | ||
Previous Close | $20.91 | ||
Volume | 452,078 | ||
30-Day Average Volume | 861,653 | ||
1-Week Change | 0.96% | ||
1-Month Change | 0.38% | ||
1-Year Change | 15.33% | ||
3-Year Change | 64.02% | ||
5-Year Change | 29.68% | ||
Fundamentals | |||
Shares Outstanding | 72.2M | ||
Total Assets | $1.7B | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.2B | ||
Period: QTR TTM FY | |||
Revenue | $56.3M | ||
Net Income | -$83.4M | ||
Free Cash Flow | $51.5M | ||
EBIT | -$102.5M | ||
EBITDA | -$95.9M | ||
Net Working Capital | $706.3M | ||
EPS | -$1.14 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | 21 | ||
P/B | 1 | ||
P/E | -18 | ||
PEG | 0 | ||
Price/Free Cash Flow | 30 | ||
Price/Operating Cash Flow | 29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 09/08/2015 | ||
Last Split Factor | 1 : 100 | ||
Last Split Date | 06/17/2013 | ||
Earnings & Revenue